 NEW YORK, Jan. 27, 2021 PRNewswire -- Q BioMed Inc. OTCQB: QBIO, announced today that the U.S. Food and Drug Administrations Office of Orphan Products Development has granted Orphan Drug Designation to Uttroside-B, a small molecule chemotherapeutic for the treatment of hepatocellular... 